|本期目录/Table of Contents|

[1]王楠,宋小骏,蒋凤,等.维拉帕米及艾灸对长春新碱耐药胃癌细胞株SGC7901逆转增效作用[J].医学研究与战创伤救治(原医学研究生学报),2017,19(06):587-591.[doi:10.3969/j.issn.1672-271X.2017.06.007]
　WANG Nan,SONG Xiao-jun,JIANG Feng,et al.Reversaland synergisticeffect of verapamil and moxibustion on vincristine resistance in mice with SGC7901 gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(06):587-591.[doi:10.3969/j.issn.1672-271X.2017.06.007]
点击复制

维拉帕米及艾灸对长春新碱耐药胃癌细胞株SGC7901逆转增效作用()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年06期
页码:
587-591
栏目:
出版日期:
2017-11-23

文章信息/Info

Title:
Reversaland synergisticeffect of verapamil and moxibustion on vincristine resistance in mice with SGC7901 gastric cancer
作者:
王楠; 宋小骏; 蒋凤; 谢学建
作者单位：210002南京，南京军区南京总医院药品科
Author(s):
WANG Nan; SONG Xiao-jun; JIANG Feng; XIE Xue-jian
(Department of Pharmacy，Nanjing General Hospital of Nanjing Military Region, PLA，Nanjing 210002，Jiangsu，China)
关键词:
维拉帕米; 艾灸; SGC7901胃癌; 长春新碱; 耐药; 逆转增效
Keywords:
Verapamil; Moxibustion; SGC7901 gastric cancer; Vincristine; Drug resistance; Reversalandsynergism
分类号:
R9
DOI:
10.3969/j.issn.1672-271X.2017.06.007
文献标志码:
A
摘要:
目的观察维拉帕米（VPM）及艾灸对小鼠长春新碱(VCR)耐药SGC7901胃癌移植后的瘤体重量、抑瘤率及P-糖蛋白（P-gp）表达的影响，以了解两者对长春新碱耐药逆转增效作用。方法分别进行不同剂量维拉帕米及艾灸联合不同剂量维拉帕米抗肿瘤耐药的实验。第一组实验将SD小鼠分成等渗盐水组、VCR对照组、VPM对照组、0.5mg/kgVPM+VCR组、1.0mg/kgVPM+VCR组、1.5mg/kgVPM+VCR组、2.0mg/kgVPM+VCR组，，每组16只，雌雄各半，所有模型组小鼠在左前肢腋下接种瘤组织，按组给予等渗盐水和不同剂量药物，15d后，取出瘤体称重，计算抑瘤率，同时留取瘤体标本，检测多药耐药(MDR)相关蛋白P-gp的变化。第二组实验将SD小鼠分成等渗盐水组、VCR对照组、VPM对照组、艾灸对照组、0.5mg/kgVPM+VCR+艾灸组、1.0mg/kgVPM+VCR+艾灸组、1.5mg/kgVPM+VCR+艾灸组、2.0mg/kgVPM+VCR+艾灸组，每组16只，雌雄各半，所有模型组小鼠在左前肢腋下接种瘤组织，按组给予等渗盐水和不同剂量药物及艾灸，15d后，取出瘤体称重，计算抑瘤率，同时留取瘤体标本，检测MDR相关蛋白P-gp的变化。结果第一组实验中给予维拉帕米时，等渗盐水组与不同剂量药物组间差异有统计学意义（P<0.05），随剂量增加瘤体重量下降、抑瘤率增加和蛋白P-gp表达下降，但1.5mg/kg和2.0mg/kg时，蛋白P-gp值差异无统计学意义。第二组实验中给予维拉帕米和艾灸时，等渗盐水组与不同剂量药物组间差异也有统计学意义（P<0.05），随剂量增加瘤体重量下降、抑瘤率增加和蛋白P-gp表达下降，其中剂量组:1.5mg/kg和2.0mg/kg与仅给予维拉帕米组相比差异有统计学意义（P<0.05）。结论维拉帕米和艾灸对小鼠长春新碱耐药SGC7901胃癌耐药具有逆转增效作用，在2.0mg/kg维拉帕米、0.5mg/kg长春新碱、艾灸联合用药时可达到单用1.0mg/kg长春新碱用药效果。
Abstract:
ObjectiveThe purpose of this study is to investigate the effect of verapamil and moxibustion on the tumor inhibitory rate and the tumor weight and the expression of P- glycoprotein after the transplantation of vincristine (VCR) resistant SGC7901 gastric cancer in mice, so as to understand the reversal effect of these two drugs on vincristine resistance.MethodsIn first group SD mice were divided into normal saline group, vincristine control group, Verapamil control group, No.1 drug group, No.2 drug group, No.3 drug group, No.4 drug group, 16 rats in each group, Half and half on male and female, all mice inoculated with tumor tissue in the left forelimb, and administered with different doses of drugs and moxibustion. On 15 days later, inhibition rate of the tumor was calculated. At the same time for tumor specimens, changes of MDR related protein P-gp are detected. In second group SD mice were divided into normal saline group, vincristine control group, Verapamilcontrol group, Moxibustion group, No.1 drug + Moxibustion group, No.2 drug + Moxibustion group, No.3 drug + Moxibustion group, No.4 + Moxibustion drug group, 16 rats in each group, Half and half on male and female, all mice inoculated with tumor tissue in the left forelimb, and administered with different doses of drugs and moxibustion. On 15 days later, inhibition rate of the tumor was calculated. At the same time for tumor specimens, changes of MDR related protein P-gp are detected.ResultsOnly to give the Verapamil treatment, there was significant difference between the Saline group and different dose groups (P<0.05), the tumor inhibition rate increased and the tumor weight and protein P-gp decreased along with the increase of the drug dose; At the 1.5 mg/kg and 2.0 mg/kg, there was no significant difference in protein P-gp. To give Verapamil and Moxibustion treatment, there is also a significant difference in the saline group and different dose groups (P<0.05), and the tumor inhibition rate increased and the tumor weight and protein P-gp decreased along with the increase of the dose. At the dose group (1.5 mg/kg and 2.0 mg/kg) there were significant differences between the treatment group compared with group of the given only Verapamil (P<0.05).ConclusionVerapamil and Moxibustion on mice of Vincristine (VCR) resistant SGC7901 gastric cancer has reverse effect, and which effect can be equivalent to one of 1.0 mg/kg VCR when Verapamil is 2.0 mg/kg and VCR is 0.5 mg/kg with Moxibustion therapy

参考文献/References:

[1]Fang G, Yang YL, Li JS,et al.R-dl-verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin[J]. Acta Pharmacol Sin，1999,20(7):647-650.
[2]Bellamy WT，Dalton WS，Kailey JM，et al. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage[J].Cancer Res，1988，48（22）:6365-6370.
[3]方刚,侯亚义,杨玉龙,等. R-型维拉帕米逆转肿瘤细胞多药耐药的实验研究[J].医学研究生学报,2000,13(5):285-288.
[4]平玉杰,赵丽辉,霍伟英,等.吡柔比星联合维拉帕米膀胱灌注对膀胱癌术后复发的预防效果分析[J].中国性科学,2013,22(7):12-14.
[5]王飞通,汪正伟,刘小云,等.维拉帕米对体内外胰腺癌SW1990细胞侵袭转移影响及其机制探讨[J].中华肿瘤防治杂志,2015,22(1):39-44.
[6]徐天舒,王玉娟,李明,等.麦粒灸后三里穴对环磷酰胺化疗肿瘤小鼠免疫功能的影响[J].江苏中医药,2013,45(11):72-74.
[7]张乐,徐腾,廖军,等.艾灸对肝癌裸鼠移植瘤PCNA、Cyclin D1、CDK4表达影响的实验研究[J].时珍国医国药,2014,25(4):1001-1003.
[8]郝智慧,徐兰凤.艾灸抗肿瘤作用研究概况[J].江苏中医药,2014,46(1)：79-81.
[9]何娟,刘晓磊,彭文兴. P-糖蛋白介导的肿瘤多药耐药逆转机制研究进展[J]. 中国药房,2006,17(3):218-220.
[10]蔡利军,宋淑萍,吕宾,等.温郁金醇提物对人耐长春新碱胃腺癌细胞SGC-7901皮下移植瘤的逆转作用及对P糖蛋白表达的影响[J].中国中西医结合杂志,2014，34(11):1347-1353.
[11]武兵,庞家秉,韩霞,等.榭皮素对耐长春新碱U251/Vin细胞多药耐药的逆转作用[J].中国临床研究,2014，27(3):272-276.
[12]张敏娟,张庆瑜,康春生,等.维拉帕米逆转胃癌细胞系SGC7901/VCR多药耐药性的研究[J]. 国际消化病杂志,2008,28(2):166-168.
[13]邢璐,崔纯莹,王玉记,等.巯嘌呤/维拉帕米-介孔氧化硅释药系统的构建及逆转耐药活性研究[J].首都医科大学学报,2015,36(2):161-165.
[14]梅梅,张翼,任金红,等.新型紫杉烷化合物 NPB304 及其协同维拉帕米逆转耐药的研究[J].药学学报,2014,49(9):1279-1288.
[15]付铃,万茜,徐天舒.麦粒灸对Lewis荷瘤小鼠Treg细胞表达的影响[J].针灸临床杂志,2015,31(1):58-60.

相似文献/References:

[1]王达理,楼建英,张 伟,等.维拉帕米对心肌细胞的保护与毒性作用[J].医学研究与战创伤救治(原医学研究生学报),2010,12(01):21.
　WANG Da-li,LOU Jian-yin,ZHANG Wei,et al.The protection and cytotoxity of verapamil on heart cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(06):21.

备注/Memo

备注/Memo:
基金项目：江苏省药学会-奥赛康医院药学科研基金项目（201201）
更新日期/Last Update: 2017-11-20